Royal Philips has unveiled its new Zenition mobile C-arm imaging platform, which can provide live image guidance during surgical procedures.
Based on X-ray technology, Zenition features image capture and image processing capabilities similar to the company’s image-guided therapy platform Azurion, which was introduced in 2017.
The new imaging platform is intended to aid hospitals in maximising operating room (OR) performance and boosting clinical capabilities.
In addition, the Zenition mobile C-arm can be moved easily between operating rooms. It is simple to position around the patient and allows intuitive operability.
Philips Image Guided Therapy Systems business leader Ronald Tabaksblat said: “As patient numbers rise and procedures become more complex, equipment up-time, utilisation and usability become ever more important.
“Our new harmonised Zenition mobile C-arm platform offers the proven performance and ease of use needed for surgical teams to work with, confidence and precision, now and in the future.”
The health technology company added that the new device supports increased OR performance across the healthcare facility.
Philips Zenition is said to enable fast and intuitive point-and-shoot image capture during any type of interventional or surgical procedure, including orthopaedic, trauma and vascular procedures.
The platform’s Position Memory feature and BodySmart software are said to capture fast and consistent images. The capability is applicable even at the edge of the image intensifier or flat detector, which minimises the need for C-arm repositioning by 45%.
It also incorporates MetalSmart software that automatically adjusts the images’ contrast and brightness in order to improve quality during the presence of metal objects such as implants in the field of view.
Zenition mobile C-arm imaging platform holds the European CE-Mark and the US Food and Drug Administration (FDA) 510(k) clearance.
The device will be commercially available in the US, Germany, Austria and Switzerland in the first half of this year. The company intends to expand it to additional markets in the future.